Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
  2. >
  3. Stock
  4. >
  5. CNMD
  6. >
  7. Earnings
stocks logo

CNMD Earnings

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings

Earning Analysis

Welcome to our in-depth analysis of Conmed Corp(CNMD) earnings, offering investors a detailed look into the company’s financial performance, revenue trends, earnings per share (EPS), and market reactions. This page provides a comprehensive overview of Conmed Corp earnings history, forecasts, and key financial metrics, empowering you with the data needed to make informed investment decisions. Whether you're tracking quarterly results, analyzing earnings surprises, or exploring future projections, our detailed breakdown covers it all.

Earnings Forecast

Revenue
EPS
Currency: USD
Actual
Estimate

Surprise Analysis

Name
EPS
Revenue
Price Reaction
Fiscal QuarterEarning DateTimeEstimateActualSurprise%EstimateActualSurprise%1D5D
Fiscal Quarter
Earning Date
Time
Estimate
Actual
Surprise%
Estimate
Actual
Surprise%
1D
5D
FY2025Q32025-11-05After Hours1.051.08+2.86334.76M337.93M+0.95-0.52+0.61
FY2025Q22025-07-30After Hours1.131.15+1.77338.42M342.35M+1.16+2.01+6.70
FY2025Q12025-04-30After Hours0.810.95+17.28313.38M321.26M+2.51+16.45+13.85
FY2024Q42025-02-05After Hours1.201.34+11.67341.05M345.94M+1.44-8.97-15.54
FY2024Q32024-10-30After Hours0.991.05+6.06317.70M316.70M-0.31+4.57+15.91
FY2024Q22024-07-31-0.920.98+6.52334.37M332.10M-0.68-0.69-5.90
FY2024Q12024-04-24-0.740.79+6.76306.72M312.27M+1.81-1.82-4.67
FY2023Q42024-01-31-1.111.06-4.50332.20M327.05M-1.55+0.82-12.04
FY2023Q32023-10-25-0.830.90+8.43300.85M304.58M+1.24-3.12+2.99
FY2023Q22023-07-26-0.790.83+5.06306.09M317.65M+3.78+2.08-1.61
AI Stock Picker
AI Stock Picker

CNMD Earnings Analysis

Our earnings analysis provides a granular look at the company’s performance across recent fiscal quarters, highlighting key metrics such as revenue, EPS, and operating margins. By examining actual results against analyst estimates, we uncover trends and surprises that drive stock price movements, offering valuable insights for both short-term traders and long-term investors.
In the most recent quarter, Conmed Corp reported performance for FY2025Q3, announced on 2025-11-05. The company achieved an EPS of 1.08, compared to analyst estimates of 1.05 by 2.86% . Revenue for the quarter reached 337.93M compared to expectations of 334.76M by 0.95% .
The stock price reacted with a -0.52% one-day change and a 0.61% five-day change following the earnings release. These movements reflect market reaction in Conmed Corp growth trajectory and strategic initiatives.

CNMD Earnings Forecast

Looking ahead, Conmed Corp(CNMD) remains a focal point for investors seeking growth opportunities. Analyst forecasts for 2025/Q4 project quarter revenue of 366.82M and an EPS of 1.32.
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2025 have been Revise Upward by 0.05%, while EPS estimates have been Revise Upward by 0.63%. For the upcoming Q4 2025, revenue estimates have been adjusted Revise Downward by -0.5% . These revisions correlate with a -19.52% change in stock price over the same period, suggesting potential buying opportunities for investors who believe in Conmed Corp long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.

Estimate Revision

The chart shows the correlation between CNMD's stock price and earnings forecast revisions. Positive revisions in Revenue or EPS often strengthen the stock's fundamentals, making price dips potential buying opportunities.
Revenue Estimates for FY2025
Revise Upward
up Image
+0.05%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+0.63%
In Past 3 Month
Revenue Estimates for Q4 2025
Revise Downward
down Image
-0.5%
In Past 3 Month
Stock Price
Go Down
down Image
-19.52%
In Past 3 Month
1Y
3Y
5Y
Annual FY 2025
Currency: USD
Currency: USD
1Y
3Y
5Y
--
Revenue Estimate-Annual FY 2025:1.37B
--
EPS Estimate-Annual FY 2025:4.50
—
Stock Price44.24
Financial AI Agent
Financial AI Agent

CNMD Revenue and EPS Performance: A Historical Perspective

Conmed Corp revenue and earnings per share (EPS) performance over recent quarters provides a clear picture of its financial health. Below is a detailed breakdown of the company’s earnings history, showcasing actual results, analyst estimates, and surprise percentages for key fiscal quarters:
FY2025Q3 (2025-11-05,After Hours):
EPS: 1.08 (Actual) vs.1.05 (Estimate) (2.86%)
Revenue: 337.93M (Actual) vs. 334.76M (Estimate) (0.95%)
Price Reaction: -0.52%(1-Day), 0.61%(5-Day)
FY2025Q2 (2025-07-30,After Hours):
EPS: 1.15 (Actual) vs.1.13 (Estimate) (1.77%)
Revenue: 342.35M (Actual) vs. 338.42M (Estimate) (1.16%)
Price Reaction: 2.01%(1-Day), 6.70%(5-Day)
FY2025Q1 (2025-04-30,After Hours):
EPS: 0.95 (Actual) vs.0.81 (Estimate) (17.28%)
Revenue: 321.26M (Actual) vs. 313.38M (Estimate) (2.51%)
Price Reaction: 16.45%(1-Day), 13.85%(5-Day)
Earnings Reaction
The chart below shows how CNMD performed 10 days before and after its earnings report, based on data from the past quarters. Typically, CNMD sees a +5.46% change in stock price 10 days leading up to the earnings, and a +0.29% change 10 days following the report. On the earnings day itself, the stock moves by -0.63%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in SEP/2025, the stock changed -0.52% on the day following the earnings release and then changed by -8.84% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
Intellectia AI SwingMax
Intellectia AI SwingMax

Transcript Summary

Conmed Corp (CNMD) Q3 2025 Earnings Call Summary
Neutral
2025-11-05
The earnings call presents a mixed picture: while there is a slight increase in EPS and cash flow, there are concerns about declining gross margins, a significant drop in GAAP net income, and management's reluctance to provide future guidance. The leverage ratio improvement and AirSeal's growth are positives, but the orthopedic backlog and tariff impacts are negatives. The market cap suggests moderate volatility, leading to a neutral stock price prediction.
Conmed Corp (CNMD) Q2 2025 Earnings Call Summary
Positive
2025-07-30
The earnings call shows a positive sentiment due to strong financial performance, increased revenue and EPS guidance, and operational improvements. Despite high debt levels and market competition, the company is making progress in supply chain and innovation. The Q&A section confirms stable market conditions and legislative support for growth. The market cap indicates a moderate reaction, leading to a prediction of a positive stock price movement (2% to 8%) over the next two weeks.
Conmed Corp (CNMD) Q1 2025 Earnings Call Summary
Neutral
2025-04-30
The earnings call presents a mixed outlook. While there are positive aspects such as increased adjusted EPS guidance and revenue growth, challenges like supply chain issues and tariff impacts persist. The Q&A section reveals management's confidence but also a lack of clarity on certain issues. The company's financials show moderate growth and improvements, but the absence of a share repurchase program and macroeconomic uncertainties add caution. Given the company's moderate market cap, these factors suggest a neutral stock price movement over the next two weeks.
Conmed Corp (CNMD) Q1 2025 Earnings Call Summary
Neutral
2025-04-30
The earnings call presents mixed signals. Financial performance shows moderate growth, with a slight increase in sales and adjusted net income. However, there are concerns about supply chain issues, tariff impacts, and lack of clarity in management's responses, which could weigh on investor sentiment. The absence of a shareholder return plan and the macroeconomic uncertainties further contribute to a neutral outlook. Given the company's mid-cap status, the stock is unlikely to experience significant movement, leading to a neutral prediction of -2% to 2%.
Conmed Corp (CNMD) Q4 2024 Earnings Call Summary
Positive
2025-02-06
The earnings report shows strong financial performance with record high revenues and significant improvements in margins. Despite some supply chain challenges, the company has engaged a consulting firm to address these issues. The AirSeal platform continues to show strong demand and growth prospects. Management's cautious guidance is balanced by the potential for upside, and the company is actively managing debt. The market cap suggests a moderate reaction, leading to a positive outlook for the stock price over the next two weeks.
CONMED Corporation (CNMD) Q3 2024 Earnings Call Summary
Neutral
2024-10-31
Despite record high sales and positive EPS growth, supply chain issues and hurricane impacts cast uncertainty. Management's vague responses in the Q&A further dampen sentiment. Guidance adjustments, particularly lower revenue guidance, coupled with no share buyback program, offset positive financial metrics. Given the company's market cap, the stock is likely to experience neutral movement (-2% to 2%) over the next two weeks.
CONMED Corporation (CNMD) Q2 2024 Earnings Call Summary
Neutral
2024-08-01
The earnings call presents a mixed picture. While the company reported growth in sales and adjusted net income, supply chain challenges and competitive pressures are concerning. The lowered guidance and lack of a share repurchase plan are negatives, but the expected margin improvements and strong financial metrics partially offset these concerns. The Q&A reveals management's cautious optimism about recovery, but uncertainties remain. Given the market cap, the stock is likely to remain stable, resulting in a neutral prediction for the next two weeks.

People Also Watch

FAQ

arrow icon

What were the key highlights of CNMD’s latest earnings report for FY2025Q3?

CNMD reported its FY2025Q3 earnings on 2025-11-05, showcasing a revenue of 337.93M against an estimate of 334.76M, resulting in a 0.95% surprise. The EPS was 1.08, surpassing the expected 1.05 by 2.86% . The stock experienced a -0.52% price change on the earnings day and a 0.61% change over the next five days, reflecting market reactions to the results.
arrow icon

How did CNMD’s stock price react after the FY2025Q3 earnings release?

Following CNMD’s FY2025Q3 earnings announcement on 2025-11-05, the stock price moved by -0.52% on the day of the release. Over the subsequent five days, it saw a 0.61% change. Historically, CNMD’s stock price tends to shift by an average of +5.46% in the 10 days leading up to earnings and +0.29% in the 10 days following, providing insight into potential market.
arrow icon

What are the revenue and EPS estimates for CNMD for 2025/Q4?

For 2025/Q4, analysts estimate CNMD’s annual revenue to reach 366.82M, while the EPS is projected at 1.32. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Upward by 0.05% and EPS estimates Revise Downward by -0.5% over the past three months, indicating analyst expectation in the company’s performance.
arrow icon

How does CNMD’s stock price correlate with earnings forecast revisions?

The correlation between CNMD’s stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Upward by 0.05%, while EPS estimates moved Revise Downward by -0.5% . This trend suggests that price dips could present buying opportunities for investors.
arrow icon

What should investors expect from CNMD’s next earnings report?

Based on historical trends, CNMD’s stock price typically moves by +5.46% in the 10 days before its earnings and +0.29% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 1.32 and revenue of 366.82M.
arrow icon

What is the sentiment in Conmed Corp (CNMD) Q3 2025 Earnings Call Summary?

The earnings call presents a mixed picture: while there is a slight increase in EPS and cash flow, there are concerns about declining gross margins, a significant drop in GAAP net income, and management's reluctance to provide future guidance. The leverage ratio improvement and AirSeal's growth are positives, but the orthopedic backlog and tariff impacts are negatives. The market cap suggests moderate volatility, leading to a neutral stock price prediction.
Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free